Market Cap 1.50B
Revenue (ttm) 614.38M
Net Income (ttm) -18.52M
EPS (ttm) N/A
PE Ratio 17.05
Forward PE 13.41
Profit Margin -3.01%
Debt to Equity Ratio 0.74
Volume 210,200
Avg Vol 344,814
Day's Range N/A - N/A
Shares Out 21.77M
Stochastic %K 74%
Beta 0.49
Analysts Strong Sell
Price Target $81.88

Latest News on ANIP

ANI Pharmaceuticals: More Than Just A Generics Company

Feb 11, 2025, 9:08 AM EST - 2 months ago

ANI Pharmaceuticals: More Than Just A Generics Company


Alcami Announces CEO Transition

Jan 13, 2025, 11:12 AM EST - 3 months ago

Alcami Announces CEO Transition


ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

Oct 11, 2024, 4:01 AM EDT - 6 months ago

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market